Lungpacer Diaphragm Pacer Gets FDA Emergency Use Authorization for COVID-19

Lungpacer Medical, based in Vancouver, Canada, announced that its Diaphragm Pacing Therapy (DPT) System received FDA Emergency Use Authorization for use in weaning COVID-19 patients off of ventilators.

Patients on prolonged mechanical ventilation may experience diaphragm disuse atrophy and ventilator-induced diaphragmatic dysfunction (V (Read more...)

Full Story →